Foundation Medicine: When making treatment decisions, knowledge is power

An advanced cancer diagnosis can change your life. You and your loved ones may feel overwhelmed with questions.

If you don’t know where to start when thinking about treatment options, there’s something you can do. Start With Step One—ask your doctor about the Foundation Medicine testing options, including the,and.

Foundation Medicine tests use comprehensive genomic profiling, also known as CGP, to find information in your tumor’s DNA that may help your doctor identify a personalized cancer treatment plan that is right for you.

Understanding your tumor’s DNA may inform the treatment options available to you. Learn more in the video. 

Step 1:Gather all the required documents

Please make sure the following forms are completed or discussed with the patient:

(Patient Authorization - to keep in your records)

Step 2: Submit your Requisition

Order a Foundation Medicine service through our Canadian Foundation Medicine Ordering Portal. Please, always attach the following documents with your order

• Pathology Report

• Foundation Navigate Form

Step 3 : Once your requisition has been successfully submitted

Our Team will contact the payor to collect the payment prior to testing

Step 4 : Specimen Retrieval and Shipment : For tissue samples

Our team will provide the collection kit, instructions, Test Requisition Form (TRF), and shipping labels to the pathology lab for sending the sample to Foundation Medicine.

Step 4 : Specimen Retrieval and Shipment : For blood samples

Our team will contact the patient to schedule the blood draw and provide the clinic with the collection kit, instructions, Test Requisition Form (TRF), and shipping labels to send the sample to Foundation Medicine.

Step 5 : Testing

Once the specimen has been delivered to Foundation Medicine, a specialized team will begin the testing process

Step 6 : Medical Report

A genomic profiling report is generated and provided to the ordering physician. Healthcare professionals use the profiling report to assist in creating treatment plans for their patients.

Legal statement policy

FoundationOne®CDx, FoundationOne®Liquid CDx, and FoundationOne®Heme are next-generation sequencing services performed by Foundation Medicine, Inc. at laboratories in the USA. 

Hoffmann-La Roche Limited markets these services in Canada under an exclusive license from Foundation Medicine, Inc. These services were developed and their performance characteristics determined by Foundation Medicine. As in-house laboratory-developed tests, the services have not been submitted to Health Canada for evaluation and are not subject to Health Canada approval. Reports generated from these services are prepared by Foundation Medicine, without Hoffmann-La Roche Limited’s involvement, and may include scientific information about experimental medicinal products or uses that are not approved or available in Canada.

This website is neither intended nor designed to record or report adverse event information. If you have a suspected side effect or problem to report regarding a Roche product, please email [email protected] or call 1-877-273-3433. You can also report adverse events relating to any product to Health Canada directly by going to the Canada Vigilance Program website at https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/adverse-reaction-reporting.html.

This website contains materials intended only for residents of Canada, and may contain product details or information not available or valid outside of Canada. We accept no responsibility for users outside of Canada accessing portions of this website which may be invalid or non-compliant with the laws, regulations or standards of the user’s home country.